Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

Vivos Inc (RDGL)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.1745 +0.0050    +2.95%
31/05 - Closed. Currency in USD ( Disclaimer )
After Hours
0.1688
-0.0057
-3.2665%
15:59:56 - Delayed Data
Type:  Equity
Market:  United States
  • Volume: 812,283
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.1608 - 0.1778
Vivos 0.1745 +0.0050 +2.95%

RDGL Balance Sheet

 
Featured here, the Balance Sheet for Vivos Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Collapse All
Period Ending: 2024
31/03
 2023
31/12
 2023
30/09
 2023
30/06
Total Current Assets 1.38 1.61 1.57 1.79
Cash and Short Term Investments 1.37 1.59 1.54 1.75
Cash - - - -
Cash & Equivalents 1.37 1.59 1.54 1.75
Short Term Investments - - - -
Total Receivables, Net 0.012 0.007 0.008 0.006
Accounts Receivables - Trade, Net 0.012 0.007 0.008 0.006
Total Inventory - - - -
Prepaid Expenses - 0.011 0.022 0.035
Other Current Assets, Total - - - -
Total Assets 1.38 1.61 1.57 1.79
Property/Plant/Equipment, Total - Net - - - -
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total - - - -
Other Assets, Total -0.012 -0.007 -0.008 -0.006
Total Current Liabilities 0.075 0.245 0.107 0.113
Accounts Payable 0.075 0.245 0.097 0.113
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt - - 0.01 -
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total - - - -
Total Liabilities 0.075 0.245 0.107 0.113
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total - - -0.01 -
Total Equity 1.31 1.37 1.46 1.68
Redeemable Preferred Stock, Total 9.63 9.63 9.63 9.63
Preferred Stock - Non Redeemable, Net 0.003 0.003 0.003 0.003
Common Stock, Total 0.39 0.388 0.371 0.371
Additional Paid-In Capital 74.29 73.79 72.83 72.38
Retained Earnings (Accumulated Deficit) -83.01 -82.45 -81.37 -80.71
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - - -
Total Liabilities & Shareholders' Equity 1.38 1.61 1.57 1.79
Total Common Shares Outstanding 390.03 387.89 370.54 370.54
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

RDGL Comments

Write your thoughts about Vivos Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jason Dessiaume
Jason Dessiaume May 01, 2024 8:02PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Any body know why this hunk of junk is performing
Reply
0 0
Report
Kathy Bagnell
Kathy Bagnell Mar 31, 2023 9:00PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
my bank sold the stock on me hmmm I wonder why total set up
Reply
0 0
Report
Willie Scott
Willie Scott Jun 29, 2022 1:52PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Have there been any other reports from the FDA???
Reply
0 0
Report
Kathy Bagnell
Kathy Bagnell Jun 29, 2022 1:52PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
There was news today you should check it out
Reply
0 0
Report
Richard Anderson
Richard Anderson Jun 03, 2021 8:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Starting the run up to FDA IDE.  Boston Scientific's TheraSpheres product which is different but same radionuclide was used under IDE for almost 20 years.   A lot of money can be made in this space without having full FDA approval.  FDA IDE is the big step to start using in humans.  I expect a run back up to at least $0.36 leading up to FDA IDE.
Reply
1 0
Report
Brandon Kent
Brandon Kent May 17, 2021 7:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Sorry about the multiple posts, they weren't showing up so I submitted a few times haha.
Reply
1 0
Report
Brandon Kent
Brandon Kent May 17, 2021 7:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Currently holding 100k shares, the science behind this medical technology is sound (from a nuclear science standpoint), and I personally feel that the success of the pet version (Isopet) leads to a much more likely outcome that it will be a successful human treatment for cancerous, nonresectable (inoperable) tumors.
Reply
1 0
Report
Brandon Kent
Brandon Kent May 17, 2021 7:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Currently holding 100k shares, the science behind this medical technology is sound (from a nuclear science standpoint), and I personally feel that the success of the pet version (Isopet) leads to a much more likely outcome that it will be a successful human treatment for cancerous, nonresectable (inoperable) tumors.
Reply
0 0
Report
Brandon Kent
Brandon Kent May 17, 2021 7:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Currently holding 100k shares, the science behind this medical technology is sound (from a nuclear science standpoint), and I personally feel that the success of the pet version (Isopet) leads to a much more likely outcome that it will be a successful human treatment for cancerous, nonresectable (inoperable) tumors.
Reply
0 0
Report
Giuseppe Giannachi
Giuseppe Giannachi Feb 09, 2021 4:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hi! I would love to join in, but the company is so small that it's hard to gather news, info, data. Anyone? Thanks. Cheers!
Reply
0 0
Report
G S qr
G S qr Feb 09, 2021 4:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Why don't you research the company online.  Tones of info.  Then decide.  Or stick with what you know.
Reply
0 0
Report
Lisa Watkins
Lisa Watkins Feb 08, 2021 6:15PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bought 14000
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email